UK science advisers warn of darker COVID-19 days ahead LONDON (AP) — Britain’s top medical advisers on Monday painted a grim picture of exponential growth in illness and death if nothing is done to control the second wave of coronavirus infections,... AP NEWS

LONDON (AP) — Britain’s top medical advisers on Monday painted a grim picture of exponential growth in illness and death if nothing is done to control the second wave of coronavirus infections, laying the groundwork for the government to announce new restrictions later this week.

https://apnews.com/a01ddfa2e8ef839b2ee05e2cbcd63169?utm_source=Sailthru&utm_medium=email&utm_campaign=AP%20Morning%20Wire&utm_term=Morning%20Wire%20Subscribers

STOCKHOLM (AP) — A train pulls into the Odenplan subway station in central Stockholm, where morning commuters without masks get off or board before settling in to read their smartphones.

Whether on trains or trams, in supermarkets or shopping malls — places where face masks are commonly worn in much of the world — Swedes go about their lives without them.

When most of Europe locked down their populations early in the pandemic by closing schools, restaurants, gyms and even borders, Swedes kept enjoying many freedoms.

The relatively low-key strategy captured the world’s attention, but at the same time it coincided with a per capita death rate that was much higher than in other Nordic countries.

U.S. faces a smoldering COVID-19 pandemic nationwide as flu season starts As the United States approaches the miserable mark of 200,000 deaths from the coronavirus, the pandemic is no longer focused on one or two epicenters. Lisa Shumaker U.S.

(Reuters) - As the United States approaches the miserable mark of 200,000 deaths from the coronavirus, the pandemic is no longer focused on one or two epicenters.

Drug shows promise in 1st largely minority COVID-19 study A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that... AP NEWS

A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics and Blacks.

CDC reverses controversial coronavirus guidance that said people without symptoms may not need a test The new guidance says that people without symptoms who have been in close contact with an infected person "need a test." Will Feuer CNBC

The Centers for Disease Control and Prevention on Friday reversed controversial coronavirus testing guidance that said people who were exposed to an infected person but weren’t showing any symptoms did “not necessarily need a test.”

2020.09.10 Harvard Medical Grand Rounds

Dr. Fauci discussion, with slides,  on the backround of the coronavirus, with Harvard Medical School panel.

Blood donations show the U.S. is still nowhere near herd immunity Testing donated blood for antibodies to the coronavirus highlights that the vast majority of the United States remains susceptible to infection. Helen Thompson Science News

To better understand how widely the coronavirus has spread in the United States, some researchers are turning to an unusual source of data: blood donations.

Report: Much needs doing to shield nursing homes from virus WASHINGTON (AP) — The Trump administration is claiming “resounding vindication” from an independent commission's report on the coronavirus crisis in nursing homes, but some panel members say... AP NEWS

WASHINGTON (AP) — The Trump administration is claiming “resounding vindication” from an independent commission’s report on the coronavirus crisis in nursing homes, but some panel members say that’s a misinterpretation of their conclusion that much remains to be done to safeguard vulnerable residents.

Two drug companies that are leading the race to develop coronavirus vaccines bowed to public pressure on Thursday, abandoning their traditional secrecy and releasing comprehensive road maps of how they are evaluating their vaccines.

The companies, Moderna and Pfizer, revealed details about how participants are being selected and monitored, the conditions under which the trials could be stopped early if there were problems, and the evidence researchers will use to determine whether people who got the vaccines were protected from Covid-19.

Moderna’s study will involve 30,000 participants, and Pfizer’s 44,000.